Regeneron Pharmaceuticals Inc (REGN)
741.79
-2.71
(-0.36%)
USD |
NASDAQ |
Nov 22, 15:10
Regeneron Pharmaceuticals Revenue (Annual): 13.12B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 13.12B |
December 31, 2022 | 12.17B |
December 31, 2021 | 16.07B |
December 31, 2020 | 8.497B |
December 31, 2019 | 6.558B |
December 31, 2018 | 5.146B |
December 31, 2017 | 5.872B |
December 31, 2016 | 4.860B |
December 31, 2015 | 4.104B |
December 31, 2014 | 2.820B |
December 31, 2013 | 2.105B |
December 31, 2012 | 1.378B |
December 31, 2011 | 445.82M |
December 31, 2010 | 459.07M |
December 31, 2009 | 379.27M |
December 31, 2008 | 238.46M |
December 31, 2007 | 125.02M |
Date | Value |
---|---|
December 31, 2006 | 63.45M |
December 31, 2005 | 66.19M |
December 31, 2004 | 174.02M |
December 31, 2003 | 57.50M |
December 31, 2002 | 21.99M |
December 31, 2001 | 21.97M |
December 31, 2000 | 59.28M |
December 31, 1999 | 34.50M |
December 31, 1998 | 38.30M |
December 31, 1997 | 26.90M |
December 31, 1996 | 24.10M |
December 31, 1995 | 27.40M |
December 31, 1994 | 23.20M |
December 31, 1993 | 10.60M |
December 31, 1992 | 11.50M |
December 31, 1991 | 7.30M |
December 31, 1990 | 5.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
6.558B
Minimum
2019
16.07B
Maximum
2021
11.28B
Average
12.17B
Median
2022
Revenue (Annual) Benchmarks
Amgen Inc | 28.19B |
Eli Lilly and Co | 34.12B |
Pfizer Inc | 58.50B |
Biogen Inc | 9.836B |
AbbVie Inc | 54.32B |